photo of

Details

Role Group Leader/Research Clinician
Research area Infection, Immunity and Global Health
Group Clinical Infections
Dr Penelope Bryant is a Group Leader and Research Clinician in the Clinical Infections group.
Dr Penelope Bryant is a Group Leader and Research Clinician in the Clinical Infections group.

Top Publications

  • Lenko, D, Purcell, R, Starr, M, Bryant, PA, South, M, Gwee, A. Does discharging asthma patients after one hour of treatment if clinically well affect emergency department length of stay. Journal of Paediatrics and Child Health 55(12) : 1445 -1450 2019
    view publication
  • Ibrahim, LF, Huang, L, Hopper, SM, Dalziel, K, Babl, FE, Bryant, PA. Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis. The Lancet Infectious Diseases 19(10) : 1101 -1108 2019
    view publication
  • Wang, SS, Kotecha, RS, Bernard, A, Blyth, CC, McMullan, BJ, Cann, MP, Yeoh, DK, Bartlett, AW, Ryan, AL, Moore, AS, et al. Invasive fungal infections in children with acute lymphoblastic leukaemia: Results from four Australian centres, 2003‐2013. Pediatric Blood & Cancer 66(10) : e27915 2019
    view publication
  • Andrew, EC, Connell, T, Robinson, P, Curtis, N, Massie, J, Robertson, C, Harrison, J, Shanthikumar, S, Bryant, PA, Starr, M, et al. Pulmonary Mycobacterium abscessus complex in children with cystic fibrosis: A practical management guideline. Journal of Paediatrics and Child Health 55(5) : 502 -511 2019
    view publication
  • Ibrahim, LF, Hopper, SM, Orsini, F, Daley, AJ, Babl, FE, Bryant, PA. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial. The Lancet Infectious Diseases 19(5) : 477 -486 2019
    view publication

Page 9 of 27

Related links